Excellent Microorganism Completes Series B Financing of Nearly 100 Million Yuan

Excellent Microbe is a bio-nano-microneedle technology developer, focusing on the research and development and industrialization of soluble microneedle transdermal drug delivery technology platform. Excellent Microorganism completed the B round of financing of nearly 100 million yuan, which was exclusively invested by Qianji Capital, and Taihe Capital served as the exclusive financial advisor. This round of financing will be used for the continuous commercialization of soluble microneedle technology in the consumer field and business expansion and capacity building in the medical field, helping the company to maintain rapid growth.

This article is reproduced from: https://www.itjuzi.com/investevent/13312173
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment